866-997-4948(US-Canada Toll Free)

Global Prostate Cancer Treatment Drugs Market Insights, Forecast to 2025

Published By :

QYResearch

Published Date : Oct 2018

Category :

Pharmaceutical

No. of Pages : 115 Pages

Prostate cancer is the most common cancer among men, the key risk factors for prostate cancer development is being old age, genetic, obesity and race.
In 2017, the global Prostate Cancer Treatment Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Prostate Cancer Treatment Drugs market based on company, product type, application and key regions.

This report studies the global market size of Prostate Cancer Treatment Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Prostate Cancer Treatment Drugs in these regions.
This research report categorizes the global Prostate Cancer Treatment Drugs market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

The various contributors involved in the value chain of Prostate Cancer Treatment Drugs include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Prostate Cancer Treatment Drugs include
Tolmar
Astellas Pharma
AstraZeneca
Ferring Pharmaceuticals
Johnson & Johnson
Abbott
Sanofi
Ipsen
Novartis
Bayer

Market Size Split by Type
Enzalutamid
Abiraterone
Leuprolide
Goserelin
Triptorelin
Histrelin
Degarelix
Sipuleucel-T
Docetaxel
Cabazitaxel
Market Size Split by Application
Hospital
Research Institution
Clinic
Drugstore

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Prostate Cancer Treatment Drugs market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Prostate Cancer Treatment Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Prostate Cancer Treatment Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Prostate Cancer Treatment Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Prostate Cancer Treatment Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Prostate Cancer Treatment Drugs are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Prostate Cancer Treatment Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Study Coverage
1.1 Prostate Cancer Treatment Drugs Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Prostate Cancer Treatment Drugs Market Size Growth Rate by Type
1.4.2 Enzalutamid
1.4.3 Abiraterone
1.4.4 Leuprolide
1.4.5 Goserelin
1.4.6 Triptorelin
1.4.7 Histrelin
1.4.8 Degarelix
1.4.9 Sipuleucel-T
1.4.10 Docetaxel
1.4.11 Cabazitaxel
1.5 Market by Application
1.5.1 Global Prostate Cancer Treatment Drugs Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Research Institution
1.5.4 Clinic
1.5.5 Drugstore
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Prostate Cancer Treatment Drugs Market Size
2.1.1 Global Prostate Cancer Treatment Drugs Revenue 2016-2025
2.1.2 Global Prostate Cancer Treatment Drugs Sales 2016-2025
2.2 Prostate Cancer Treatment Drugs Growth Rate by Regions
2.2.1 Global Prostate Cancer Treatment Drugs Sales by Regions
2.2.2 Global Prostate Cancer Treatment Drugs Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Prostate Cancer Treatment Drugs Sales by Manufacturers
3.1.1 Prostate Cancer Treatment Drugs Sales by Manufacturers
3.1.2 Prostate Cancer Treatment Drugs Sales Market Share by Manufacturers
3.1.3 Global Prostate Cancer Treatment Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Prostate Cancer Treatment Drugs Revenue by Manufacturers
3.2.1 Prostate Cancer Treatment Drugs Revenue by Manufacturers (2016-2018)
3.2.2 Prostate Cancer Treatment Drugs Revenue Share by Manufacturers (2016-2018)
3.3 Prostate Cancer Treatment Drugs Price by Manufacturers
3.4 Prostate Cancer Treatment Drugs Manufacturing Base Distribution, Product Types
3.4.1 Prostate Cancer Treatment Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Prostate Cancer Treatment Drugs Product Category
3.4.3 Date of International Manufacturers Enter into Prostate Cancer Treatment Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Prostate Cancer Treatment Drugs Sales by Type
4.2 Global Prostate Cancer Treatment Drugs Revenue by Type
4.3 Prostate Cancer Treatment Drugs Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Prostate Cancer Treatment Drugs Breakdown Data by Application

6 North America
6.1 North America Prostate Cancer Treatment Drugs by Countries
6.1.1 North America Prostate Cancer Treatment Drugs Sales by Countries
6.1.2 North America Prostate Cancer Treatment Drugs Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Prostate Cancer Treatment Drugs by Type
6.3 North America Prostate Cancer Treatment Drugs by Application
6.4 North America Prostate Cancer Treatment Drugs by Company

7 Europe
7.1 Europe Prostate Cancer Treatment Drugs by Countries
7.1.1 Europe Prostate Cancer Treatment Drugs Sales by Countries
7.1.2 Europe Prostate Cancer Treatment Drugs Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Prostate Cancer Treatment Drugs by Type
7.3 Europe Prostate Cancer Treatment Drugs by Application
7.4 Europe Prostate Cancer Treatment Drugs by Company

8 Asia Pacific
8.1 Asia Pacific Prostate Cancer Treatment Drugs by Countries
8.1.1 Asia Pacific Prostate Cancer Treatment Drugs Sales by Countries
8.1.2 Asia Pacific Prostate Cancer Treatment Drugs Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Prostate Cancer Treatment Drugs by Type
8.3 Asia Pacific Prostate Cancer Treatment Drugs by Application
8.4 Asia Pacific Prostate Cancer Treatment Drugs by Company

9 Central & South America
9.1 Central & South America Prostate Cancer Treatment Drugs by Countries
9.1.1 Central & South America Prostate Cancer Treatment Drugs Sales by Countries
9.1.2 Central & South America Prostate Cancer Treatment Drugs Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Prostate Cancer Treatment Drugs by Type
9.3 Central & South America Prostate Cancer Treatment Drugs by Application
9.4 Central & South America Prostate Cancer Treatment Drugs by Company

10 Middle East and Africa
10.1 Middle East and Africa Prostate Cancer Treatment Drugs by Countries
10.1.1 Middle East and Africa Prostate Cancer Treatment Drugs Sales by Countries
10.1.2 Middle East and Africa Prostate Cancer Treatment Drugs Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Prostate Cancer Treatment Drugs by Type
10.3 Middle East and Africa Prostate Cancer Treatment Drugs by Application
10.4 Middle East and Africa Prostate Cancer Treatment Drugs by Company

11 Company Profiles
11.1 Tolmar
11.1.1 Tolmar Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Prostate Cancer Treatment Drugs
11.1.4 Prostate Cancer Treatment Drugs Product Description
11.1.5 Recent Development
11.2 Astellas Pharma
11.2.1 Astellas Pharma Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Prostate Cancer Treatment Drugs
11.2.4 Prostate Cancer Treatment Drugs Product Description
11.2.5 Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Prostate Cancer Treatment Drugs
11.3.4 Prostate Cancer Treatment Drugs Product Description
11.3.5 Recent Development
11.4 Ferring Pharmaceuticals
11.4.1 Ferring Pharmaceuticals Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Prostate Cancer Treatment Drugs
11.4.4 Prostate Cancer Treatment Drugs Product Description
11.4.5 Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Prostate Cancer Treatment Drugs
11.5.4 Prostate Cancer Treatment Drugs Product Description
11.5.5 Recent Development
11.6 Abbott
11.6.1 Abbott Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Prostate Cancer Treatment Drugs
11.6.4 Prostate Cancer Treatment Drugs Product Description
11.6.5 Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Prostate Cancer Treatment Drugs
11.7.4 Prostate Cancer Treatment Drugs Product Description
11.7.5 Recent Development
11.8 Ipsen
11.8.1 Ipsen Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Prostate Cancer Treatment Drugs
11.8.4 Prostate Cancer Treatment Drugs Product Description
11.8.5 Recent Development
11.9 Novartis
11.9.1 Novartis Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of Prostate Cancer Treatment Drugs
11.9.4 Prostate Cancer Treatment Drugs Product Description
11.9.5 Recent Development
11.10 Bayer
11.10.1 Bayer Company Details
11.10.2 Company Description
11.10.3 Sales, Revenue and Gross Margin of Prostate Cancer Treatment Drugs
11.10.4 Prostate Cancer Treatment Drugs Product Description
11.10.5 Recent Development

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Prostate Cancer Treatment Drugs Raw Material
13.1.2 Prostate Cancer Treatment Drugs Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Table

List of Tables and Figures

Figure Picture of Prostate Cancer Treatment Drugs
Figure Global Prostate Cancer Treatment Drugs Production (MT) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Prostate Cancer Treatment Drugs Production Market Share by Types (Product Category) in 2017
Figure Enzalutamid Product Picture
Table Major Manufacturers of Enzalutamid
Figure Abiraterone Product Picture
Table Major Manufacturers of Abiraterone
Figure Leuprolide Product Picture
Table Major Manufacturers of Leuprolide
Figure Goserelin Product Picture
Table Major Manufacturers of Goserelin
Figure Triptorelin Product Picture
Table Major Manufacturers of Triptorelin
Figure Histrelin Product Picture
Table Major Manufacturers of Histrelin
Figure Degarelix Product Picture
Table Major Manufacturers of Degarelix
Figure Sipuleucel-T Product Picture
Table Major Manufacturers of Sipuleucel-T
Figure Docetaxel Product Picture
Table Major Manufacturers of Docetaxel
Figure Cabazitaxel Product Picture
Table Major Manufacturers of Cabazitaxel
Table Global Prostate Cancer Treatment Drugs Market Size Growth Rate by Application 2018-2025 (MT)
Figure Hospital
Figure Research Institution
Figure Clinic
Figure Drugstore
Figure Prostate Cancer Treatment Drugs Report Years Considered
Figure Global Prostate Cancer Treatment Drugs Market Size 2016-2025 (Million US$)
Figure Global Prostate Cancer Treatment Drugs Sales 2016-2025 (MT)
Table Global Prostate Cancer Treatment Drugs Market Size by Regions 2016-2025 (MT) & (Million US$)
Table Global Prostate Cancer Treatment Drugs Sales by Regions 2016-2025 (MT)
Table Global Prostate Cancer Treatment Drugs Sales Market Share by Regions 2016-2025
Figure Global Prostate Cancer Treatment Drugs Sales Market Share by Regions 2016-2025
Figure 2017 Global Prostate Cancer Treatment Drugs Sales Market Share by Regions
Table Global Prostate Cancer Treatment Drugs Revenue by Regions 2016-2025 (Million US$)
Table Global Prostate Cancer Treatment Drugs Revenue Market Share by Regions 2016-2025
Figure Global Prostate Cancer Treatment Drugs Revenue Market Share by Regions 2016-2025
Figure 2017 Global Prostate Cancer Treatment Drugs Revenue Market Share by Regions
Table Global Prostate Cancer Treatment Drugs Sales by Manufacturers (2016-2018) (MT)
Table Global Prostate Cancer Treatment Drugs Sales Share by Manufacturers (2016-2018)
Figure Global Prostate Cancer Treatment Drugs Sales Share by Manufacturers in 2017
Table Prostate Cancer Treatment Drugs Revenue by Manufacturers (2016-2018) (Million US$)
Table Prostate Cancer Treatment Drugs Revenue Share by Manufacturers (2016-2018)
Figure Prostate Cancer Treatment Drugs Value Share by Manufacturers in 2017
Table Global Prostate Cancer Treatment Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Prostate Cancer Treatment Drugs Price (2016-2018) (USD/MT)
Table Prostate Cancer Treatment Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Prostate Cancer Treatment Drugs Product Category
Table Date of International Manufacturers Enter into Prostate Cancer Treatment Drugs Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Prostate Cancer Treatment Drugs Sales by Type (2016-2025) (MT)
Table Global Prostate Cancer Treatment Drugs Sales Share by Type (2016-2025)
Figure Global Prostate Cancer Treatment Drugs Sales Market Share by Type (2016-2025)
Figure Global Prostate Cancer Treatment Drugs Sales Market Share by Type in 2017
Table Global Prostate Cancer Treatment Drugs Revenue by Type (2016-2025) (Million US$)
Table Global Prostate Cancer Treatment Drugs Revenue Share by Type (2016-2025)
Figure Global Prostate Cancer Treatment Drugs Revenue Market Share by Type (2016-2025)
Figure Global Prostate Cancer Treatment Drugs Revenue Market Share by Type in 2017
Table Prostate Cancer Treatment Drugs Price by Type 2013-2018 (USD/MT)
Table Global Prostate Cancer Treatment Drugs Sales by Application (2016-2025) (MT)
Table Global Prostate Cancer Treatment Drugs Sales Share by Application (2016-2025)
Figure Global Sales Prostate Cancer Treatment Drugs Market Share by Application (2016-2025)
Figure Global Sales Prostate Cancer Treatment Drugs Market Share by Application (2016-2025)
Figure North America Prostate Cancer Treatment Drugs Sales Growth Rate 2016-2025 (MT)
Figure North America Prostate Cancer Treatment Drugs Revenue Growth Rate 2016-2025 (Million US$)
Table North America Prostate Cancer Treatment Drugs Sales by Countries (2016-2025) (MT)
Table North America Prostate Cancer Treatment Drugs Sales Market Share by Countries (2016-2025)
Figure 2017 North America Prostate Cancer Treatment Drugs Sales Market Share by Countries
Table North America Prostate Cancer Treatment Drugs Revenue by Countries (2016-2025) (Million US$)
Table North America Prostate Cancer Treatment Drugs Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Prostate Cancer Treatment Drugs Revenue Market Share by Countries
Figure United States Prostate Cancer Treatment Drugs Sales Growth Rate (2016-2025) (MT)
Figure United States Prostate Cancer Treatment Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Prostate Cancer Treatment Drugs Sales Growth Rate (2016-2025) (MT)
Figure Canada Prostate Cancer Treatment Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Prostate Cancer Treatment Drugs Sales Growth Rate (2016-2025) (MT)
Figure Mexico Prostate Cancer Treatment Drugs Revenue Growth Rate (2016-2025) (Million US$)
Table North America Prostate Cancer Treatment Drugs Sales by Type (2016-2025) (MT)
Table North America Prostate Cancer Treatment Drugs Sales Market Share by Type (2016-2025)
Figure 2017 North America Prostate Cancer Treatment Drugs Market Share by Type
Table North America Prostate Cancer Treatment Drugs Sales by Application (2016-2025) (MT)
Table North America Prostate Cancer Treatment Drugs Sales Market Share by Application (2016-2025)
Figure 2017 North America Prostate Cancer Treatment Drugs Market Share by Application
Table North America Prostate Cancer Treatment Drugs Sales by Company (2016-2018) (MT)
Table North America Prostate Cancer Treatment Drugs Sales Market Share by Company (2016-2018)
Figure North America Prostate Cancer Treatment Drugs Sales Market Share by Company in 2017
Figure Europe Prostate Cancer Treatment Drugs Sales Growth Rate 2016-2025 (MT)
Figure Europe Prostate Cancer Treatment Drugs Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Prostate Cancer Treatment Drugs Sales by Countries (2016-2025) (MT)
Table Europe Prostate Cancer Treatment Drugs Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Prostate Cancer Treatment Drugs Sales Market Share by Countries
Table Europe Prostate Cancer Treatment Drugs Revenue by Countries (2016-2025) (Million US$)
Table Europe Prostate Cancer Treatment Drugs Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Prostate Cancer Treatment Drugs Revenue Market Share by Countries
Figure Germany Prostate Cancer Treatment Drugs Sales Growth Rate (2016-2025) (MT)
Figure Germany Prostate Cancer Treatment Drugs Revenue Growth Rate (2016-2025) (MT)
Figure France Prostate Cancer Treatment Drugs Sales Growth Rate (2016-2025) (MT)
Figure France Prostate Cancer Treatment Drugs Revenue Growth Rate (2016-2025) (MT)
Figure UK Prostate Cancer Treatment Drugs Sales Growth Rate (2016-2025) (MT)
Figure UK Prostate Cancer Treatment Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Prostate Cancer Treatment Drugs Sales Growth Rate (2016-2025) (MT)
Figure Italy Prostate Cancer Treatment Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Prostate Cancer Treatment Drugs Sales Growth Rate (2016-2025) (MT)
Figure Russia Prostate Cancer Treatment Drugs Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Prostate Cancer Treatment Drugs Sales by Type (2016-2025) (MT)
Table Europe Prostate Cancer Treatment Drugs Sales Market Share by Type (2016-2025)
Figure 2017 Europe Prostate Cancer Treatment Drugs Market Share by Type
Table Europe Prostate Cancer Treatment Drugs Sales by Application (2016-2025) (MT)
Table Europe Prostate Cancer Treatment Drugs Sales Market Share by Application (2016-2025)
Figure 2017 Europe Prostate Cancer Treatment Drugs Market Share by Application
Table Europe Prostate Cancer Treatment Drugs Sales by Company (2016-2018) (MT)
Table Europe Prostate Cancer Treatment Drugs Sales Market Share by Company (2016-2018)
Figure Europe Prostate Cancer Treatment Drugs Sales Market Share by Company in 2017
Figure Asia Pacific Prostate Cancer Treatment Drugs Sales Growth Rate 2016-2025 (MT)
Figure Asia Pacific Prostate Cancer Treatment Drugs Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Prostate Cancer Treatment Drugs Sales by Countries (2016-2025) (MT)
Table Asia Pacific Prostate Cancer Treatment Drugs Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Prostate Cancer Treatment Drugs Sales Market Share by Countries
Table Asia Pacific Prostate Cancer Treatment Drugs Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Prostate Cancer Treatment Drugs Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Prostate Cancer Treatment Drugs Revenue Market Share by Countries
Figure China Prostate Cancer Treatment Drugs Sales Growth Rate (2016-2025) (MT)
Figure China Prostate Cancer Treatment Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Prostate Cancer Treatment Drugs Sales Growth Rate (2016-2025) (MT)
Figure Japan Prostate Cancer Treatment Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Prostate Cancer Treatment Drugs Sales Growth Rate (2016-2025) (MT)
Figure Korea Prostate Cancer Treatment Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure India Prostate Cancer Treatment Drugs Sales Growth Rate (2016-2025) (MT)
Figure India Prostate Cancer Treatment Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Prostate Cancer Treatment Drugs Sales Growth Rate (2016-2025) (MT)
Figure Australia Prostate Cancer Treatment Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Prostate Cancer Treatment Drugs Sales Growth Rate (2016-2025) (MT)
Figure Indonesia Prostate Cancer Treatment Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Prostate Cancer Treatment Drugs Sales Growth Rate (2016-2025) (MT)
Figure Malaysia Prostate Cancer Treatment Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Prostate Cancer Treatment Drugs Sales Growth Rate (2016-2025) (MT)
Figure Philippines Prostate Cancer Treatment Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Prostate Cancer Treatment Drugs Sales Growth Rate (2016-2025) (MT)
Figure Thailand Prostate Cancer Treatment Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Prostate Cancer Treatment Drugs Sales Growth Rate (2016-2025) (MT)
Figure Vietnam Prostate Cancer Treatment Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Prostate Cancer Treatment Drugs Sales Growth Rate (2016-2025) (MT)
Figure Singapore Prostate Cancer Treatment Drugs Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Prostate Cancer Treatment Drugs Sales by Type (2016-2025) (MT)
Table Asia Pacific Prostate Cancer Treatment Drugs Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Prostate Cancer Treatment Drugs Market Share by Type
Table Asia Pacific Prostate Cancer Treatment Drugs Sales by Application (2016-2025) (MT)
Table Asia Pacific Prostate Cancer Treatment Drugs Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Prostate Cancer Treatment Drugs Market Share by Application
Table Asia Pacific Prostate Cancer Treatment Drugs Sales by Company (2016-2018) (MT)
Table Asia Pacific Prostate Cancer Treatment Drugs Sales Market Share by Company (2016-2018)
Figure Asia Pacific Prostate Cancer Treatment Drugs Sales Market Share by Company in 2017
Figure Central & South America Prostate Cancer Treatment Drugs Sales Growth Rate 2016-2025 (MT)
Figure Central & South America Prostate Cancer Treatment Drugs Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Prostate Cancer Treatment Drugs Sales by Countries (2016-2025) (MT)
Table Central & South America Prostate Cancer Treatment Drugs Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Prostate Cancer Treatment Drugs Sales Market Share by Countries
Table Central & South America Prostate Cancer Treatment Drugs Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Prostate Cancer Treatment Drugs Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Prostate Cancer Treatment Drugs Revenue Market Share by Countries
Figure Brazil Prostate Cancer Treatment Drugs Sales Growth Rate (2016-2025) (MT)
Figure Brazil Prostate Cancer Treatment Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Prostate Cancer Treatment Drugs Sales Growth Rate (2016-2025) (MT)
Figure Argentina Prostate Cancer Treatment Drugs Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Prostate Cancer Treatment Drugs Sales by Type (2016-2025) (MT)
Table Central & South America Prostate Cancer Treatment Drugs Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Prostate Cancer Treatment Drugs Market Share by Type
Table Central & South America Prostate Cancer Treatment Drugs Sales by Application (2016-2025) (MT)
Table Central & South America Prostate Cancer Treatment Drugs Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Prostate Cancer Treatment Drugs Market Share by Application
Table Central & South America Prostate Cancer Treatment Drugs Sales by Company (2016-2018) (MT)
Table Central & South America Prostate Cancer Treatment Drugs Sales Market Share by Company (2016-2018)
Figure Central & South America Prostate Cancer Treatment Drugs Sales Market Share by Company in 2017
Figure Middle East and Africa Prostate Cancer Treatment Drugs Sales Growth Rate 2016-2025 (MT)
Figure Middle East and Africa Prostate Cancer Treatment Drugs Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Prostate Cancer Treatment Drugs Sales by Countries (2016-2025) (MT)
Table Middle East and Africa Prostate Cancer Treatment Drugs Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Prostate Cancer Treatment Drugs Sales Market Share by Countries
Table Middle East and Africa Prostate Cancer Treatment Drugs Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Prostate Cancer Treatment Drugs Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Prostate Cancer Treatment Drugs Revenue Market Share by Countries
Figure GCC Countries Prostate Cancer Treatment Drugs Sales Growth Rate (2016-2025) (MT)
Figure GCC Countries Prostate Cancer Treatment Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Prostate Cancer Treatment Drugs Sales Growth Rate (2016-2025) (MT)
Figure Turkey Prostate Cancer Treatment Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Prostate Cancer Treatment Drugs Sales Growth Rate (2016-2025) (MT)
Figure Egypt Prostate Cancer Treatment Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Prostate Cancer Treatment Drugs Sales Growth Rate (2016-2025) (MT)
Figure South Africa Prostate Cancer Treatment Drugs Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Prostate Cancer Treatment Drugs Sales by Type (2016-2025) (MT)
Table Middle East and Africa Prostate Cancer Treatment Drugs Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Prostate Cancer Treatment Drugs Market Share by Type
Table Middle East and Africa Prostate Cancer Treatment Drugs Sales by Application (2016-2025) (MT)
Table Middle East and Africa Prostate Cancer Treatment Drugs Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Prostate Cancer Treatment Drugs Market Share by Application
Table Middle East and Africa Prostate Cancer Treatment Drugs Sales by Company (2016-2018) (MT)
Table Middle East and Africa Prostate Cancer Treatment Drugs Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Prostate Cancer Treatment Drugs Sales Market Share by Company in 2017
Table Tolmar Company Details
Table Tolmar Prostate Cancer Treatment Drugs Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Tolmar Recent Development
Table Astellas Pharma Company Details
Table Astellas Pharma Prostate Cancer Treatment Drugs Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Astellas Pharma Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Prostate Cancer Treatment Drugs Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table AstraZeneca Recent Development
Table Ferring Pharmaceuticals Company Details
Table Ferring Pharmaceuticals Prostate Cancer Treatment Drugs Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Ferring Pharmaceuticals Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Prostate Cancer Treatment Drugs Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Johnson & Johnson Recent Development
Table Abbott Company Details
Table Abbott Prostate Cancer Treatment Drugs Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Abbott Recent Development
Table Sanofi Company Details
Table Sanofi Prostate Cancer Treatment Drugs Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Sanofi Recent Development
Table Ipsen Company Details
Table Ipsen Prostate Cancer Treatment Drugs Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Ipsen Recent Development
Table Novartis Company Details
Table Novartis Prostate Cancer Treatment Drugs Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Novartis Recent Development
Table Bayer Company Details
Table Bayer Prostate Cancer Treatment Drugs Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Bayer Recent Development
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Prostate Cancer Treatment Drugs Value Chain
Table Typical Suppliers of Key Prostate Cancer Treatment Drugs Raw Material
Table Prostate Cancer Treatment Drugs Customers List
Table Prostate Cancer Treatment Drugs Sales Channels
Table Prostate Cancer Treatment Drugs Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *